03.02.2023 12:40:40

Regeneron Pharmaceuticals Q4 Profit Declines

(RTTNews) - Regeneron Pharmaceuticals (REGN) released earnings for fourth quarter that decreased from last year

The company's earnings came in at $1.20 billion, or $10.50 per share. This compares with $2.23 billion, or $19.69 per share, in last year's fourth quarter.

Excluding items, Regeneron Pharmaceuticals reported adjusted earnings of $1.45 billion or $12.56 per share for the period.

The company's revenue for the quarter fell 31.1% to $3.41 billion from $4.95 billion last year.

Regeneron Pharmaceuticals earnings at a glance (GAAP) :

-Earnings (Q4): $1.20 Bln. vs. $2.23 Bln. last year. -EPS (Q4): $10.50 vs. $19.69 last year. -Revenue (Q4): $3.41 Bln vs. $4.95 Bln last year.

Analysen zu Regeneron Pharmaceuticals Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Regeneron Pharmaceuticals Inc. 672,00 -1,06% Regeneron Pharmaceuticals Inc.